THORACOSCOPY

A Structured MD Examination Answer — 15 Marks

1. DEFINITION AND TERMINOLOGY

• Medical thoracoscopy / pleuroscopy — performed by a pulmonologist, typically under local anesthesia + conscious sedation, via 1–2 ports, with non-disposable instruments.
• Surgical thoracoscopy / VATS (Video-Assisted Thoracic Surgery) — performed by a thoracic surgeon under general anesthesia with double-lumen intubation, allowing single-lung ventilation and access to lung parenchyma, mediastinum, and pleura.
• RATS (Robotic-Assisted Thoracic Surgery) — robotic variant of VATS (Fishman's).

2. HISTORICAL BACKGROUND

3. EQUIPMENT AND TECHNIQUES

3A. Rigid Thoracoscope (Murray & Nadel)

• Standard entry via a 7 mm or 9 mm diameter trocar-cannula system
• Optical devices available at 0°, 30°, and 90° fields of view
• Mini-thoracoscope: rigid optical telescope of 3 mm diameter, requiring two ports; useful for small effusions or narrow intercostal spaces
• Single-port technique: usually sufficient; second port (5 mm trocar) used if biopsy forceps or talc atomizer needed
• Position of second site confirmed by pressing finger on chest wall and visualizing with 50° scope

3B. Semirigid (Semiflexible) Thoracoscope (Murray & Nadel)

• Outer shaft diameter 7 mm; proximal 22 cm stiff, distal 5 cm flexible (angulation 160° up / 130° down)
• Working channel 2.8 mm — accepts standard flexible bronchoscopy instruments
• Inserted through a dedicated soft trocar-cannula
• Skills transferable from bronchoscopy — favored by interventional pulmonologists
• Advantages: easier navigation of the entire pleural cavity; more uniform talc distribution; potential for narrow band imaging (NBI) to detect early malignant change
• Usually requires only a single port

3C. VATS / Surgical Thoracoscopy (Fishman's)

• Performed in operating room under general anesthesia
• Double-lumen endotracheal tube for one-lung ventilation — creates working space
• CO₂ insufflation (max <6 mmHg) optionally used to depress diaphragm and improve exposure
• 3–4 incisions, 5–12 mm, arranged in triangular configuration
• 5 mm or 10 mm fiberoptic thoracoscope connected to video camera
• Chest tube placed at end of procedure
• Simple diagnostic VATS: hospital stay 1–2 days

4. PATIENT PREPARATION

• CT chest (preferably with IV contrast) — mandatory before medical thoracoscopy to assess:
  • Size of effusion
  • Presence of loculations
  • Pleural thickening, nodules, masses
• Thoracic ultrasound before procedure improves pleural access and predicts fibrous septation
• Large-volume pleural aspiration (thoracentesis) before thoracoscopy: confirms lung expansion (required for successful pleurodesis) and obtains cytology samples
• Multidisciplinary collaboration between interventional pulmonologist and thoracic surgeon for optimal patient selection

5. ANESTHESIA

• Thoracoscopic talc pleurodesis under local anesthesia generally requires additional analgesia (poudrage is painful)

6. INDICATIONS

Diagnostic Indications:

1. Undiagnosed exudative pleural effusion — primary indication; sensitivity ~90–95% for malignant pleural disease
2. Diagnosis of malignant mesothelioma
3. Differentiation of malignant vs. benign pleural disease
4. Pleural tuberculosis (when other tests negative)
5. Assessment of diffuse pleural thickening
6. Biopsy of pleural masses or nodules
7. Staging of lung cancer (visceral/parietal pleural involvement)
8. Assessment of the mediastinum, hilum, and diaphragm (VATS)
9. Interstitial lung disease — surgical lung biopsy (VATS)
10. Pulmonary nodule characterization (VATS)

Murray & Nadel: "Thoracoscopy today is primarily a diagnostic procedure but can also be applied for therapeutic purposes."

Therapeutic Indications:

1. Talc poudrage pleurodesis — for malignant or recurrent pleural effusions; and recurrent spontaneous pneumothorax
2. Management of spontaneous pneumothorax (bullectomy/stapling via VATS)
3. Empyema — early thoracoscopy (before adhesions become too fibrous); drainage and decortication (VATS)
4. Indwelling pleural catheter (IPC) insertion during same procedure
5. Sympathectomy, splanchnicectomy (advanced interventional pulmonology)
6. Resection of pleural tumors, mediastinal masses, pulmonary wedge resections (VATS/RATS)

7. CONTRAINDICATIONS

8. THORACOSCOPIC TECHNIQUE — STEP BY STEP

1. Patient positioning: Lateral decubitus with affected side up; arm elevated
2. Site selection: 4th–5th ICS, mid-axillary line; second site (if needed) confirmed by finger indentation + scope visualization
3. Skin preparation and local anesthesia: Infiltrate skin, subcutaneous tissue, intercostal muscles, parietal pleura
4. Incision: 10–15 mm skin incision (single entry technique)
5. Trocar insertion: 7–9 mm trocar-cannula inserted through incision into pleural space
6. Pneumothorax creation: Air (or CO₂) introduced to create working space; residual fluid aspirated
7. Thoracoscope introduction: Through trocar; inspect pleural space systematically
8. Systematic inspection: Parietal pleura, visceral pleura, lung surface, diaphragm, costophrenic sulci, and mediastinal pleura
9. Directed biopsies: Multiple (≥6) biopsy samples from abnormal areas using forceps through working channel (or second port)
10. Therapeutic procedures: Talc poudrage, IPC insertion (as indicated)
11. Drainage: Chest tube inserted at end of procedure; removed once drainage minimal and lung re-expanded

9. DIAGNOSTIC YIELD AND RESULTS

• A study of 1,926 patients undergoing medical thoracoscopy: major complications (lung laceration, major bleeding, prolonged air leak, re-expansion pulmonary edema) occurred in <1%
• Mortality rate <0.5%
• Diagnostic yield of medical thoracoscopy = that of VATS, but with lower cost and shorter hospital stay

• ~5–31% of cytologically negative exudative effusions remain undiagnosed after thoracoscopy → show nonspecific pleuritis on biopsy
• ~14% of nonspecific pleuritis cases eventually diagnosed with malignancy (mostly mesothelioma)
• These patients require close follow-up for 1–2 years (Fishman's)

10. TALC POUDRAGE PLEURODESIS

• Mechanism: Talc sprayed as powder through atomizer inserted via working channel → uniform coating of pleural surfaces → inflammatory pleurodesis
• Indications: Malignant/recurrent pleural effusion; recurrent spontaneous pneumothorax
• Prerequisite: Confirm full lung expansion before poudrage (incomplete expansion = trapped lung → pleurodesis fails)
• Dose:
  • Malignant/recurrent effusion: 4 g
  • Spontaneous pneumothorax: 2 g
• Technique: Inspect distribution during insufflation to ensure uniform coverage
• Complication risk: Talc pleurodesis under local anesthesia requires additional analgesia (procedure is painful)

11. COMPLICATIONS

12. DIFFERENCES: MEDICAL THORACOSCOPY vs. VATS

Murray & Nadel: Medical thoracoscopy is "less invasive than VATS because it is performed under local anesthesia and conscious sedation, most commonly through a single port."

13. SPECIAL APPLICATIONS (VATS — Fishman's)

Malignant Pleural Effusion:

• VATS: 90–100% diagnostic yield vs. 60–80% for thoracentesis
• Can perform talc pleurodesis or insert IPC in same sitting

Empyema:

• VATS decortication for fibrinopurulent/organized stage
• Medical thoracoscopy: effective early (exudative phase) before adhesions solidify (Murray & Nadel)

Interstitial Lung Disease (ILD):

• VATS surgical lung biopsy: recommended over bronchoscopic biopsy when tissue diagnosis needed
• Multiple lobe sampling possible

Pulmonary Nodules:

• VATS wedge resection: diagnosis + treatment in single procedure
• Can proceed to lobectomy if frozen section confirms malignancy

Spontaneous Pneumothorax (VATS):

• Bullectomy/stapling of blebs
• Pleurodesis (talc poudrage or abrasion)

14. TRAINING AND COMPETENCY

• Medical thoracoscopy is part of the formal interventional pulmonology training program in both Europe and the USA
• In 2002–03 ACCP survey, only 12% of US pulmonary/critical care fellowship directors stated thoracoscopy was offered in training (indicating a training gap)
• Semirigid technique is more accessible to bronchoscopists due to shared skill set

15. SUMMARY / KEY POINTS (Murray & Nadel)

"Medical thoracoscopy (pleuroscopy) is less invasive than VATS because it is performed under local anesthesia and conscious sedation, most commonly through a single port."

• Primary indication: Undiagnosed exudative pleural effusion — especially when cytology is negative
• Diagnostic sensitivity: 90–95% for malignant pleural disease
• Mortality: <0.5%; major complications <1%
• Medical thoracoscopy = VATS in diagnostic yield, but lower cost, outpatient-suitable
• ~12% of patients still require VATS/surgery following medical thoracoscopy
• Nonspecific pleuritis on biopsy requires 1–2 years follow-up (risk of occult mesothelioma ~14%)
• Talc poudrage (4 g malignant; 2 g pneumothorax) is the most widely used pleurodesis method
• Semirigid thoracoscope has broadened access to medical thoracoscopy